Q3 2026 Champions Oncology Inc Earnings Call Transcript
Key Points
- Champions Oncology Inc (CSBR) reported another quarter of strong operational performance with record services revenue.
- The company achieved its third consecutive quarter of positive adjusted EBITDA.
- There is early momentum in the data business, with new deals closed and additional revenue expected in the fourth quarter.
- The PDX Bank remains a market differentiator, contributing to the resilience of customer relationships.
- The company is managing to invest in growth opportunities while maintaining positive adjusted EBITDA, indicating disciplined capital allocation.
- Total revenue for the quarter decreased by approximately 3% compared to the prior year period.
- There was no data revenue recognized in the third quarter, contributing to the overall year-over-year revenue decline.
- Gross margin decreased to 47% from 61% in the prior year, partly due to outsourced laboratory work costs.
- Operating expenses increased significantly, reflecting investments in strategic priorities, which impacted short-term profitability.
- Net cash used in operating activities was $1.4 million, driven by changes in working capital and decreased deferred revenue.
Greetings. Welcome to the Champions Oncology third quarter fiscal year 2026 earnings call. (Operator Instructions) Please note, this conference is being recorded.
I will now turn the conference over to your host, Rob Brainin, CEO at Champions Oncology. You may begin.
Good afternoon, and thank you for joining us for our third quarter fiscal 2026 earnings call. I'm Rob Brainin, CEO of Champions Oncology, and I'm joined today by our CFO, David Miller. Before we begin, I'll remind everyone that today's remarks may include forward-looking statements. Actual results may differ materially, and additional information can be found in our filings with the SEC. Before I walk through the quarter, let me briefly highlight three key takeaways.
First, we delivered another quarter of strong operational performance, including record services revenue and our third consecutive quarter of positive adjusted EBITDA. Second, while quarterly revenue can fluctuate in our business, we remain on
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
